Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Holding(s) in Company

15 Jun 2017 16:15

RNS Number : 2432I
Volex PLC
15 June 2017
 



 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

 

 

VOLEX PLC

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

No

 

An event changing the breakdown of voting rights

 

No

Other (please specify):

 

No

 

 

3. Full name of person(s) subject to the notification obligation: iii

(1) GoldenPeaks Active Value Limited

(2) GoldenPeaks Limited

(3) GoldenPeaks Capital Management Limited

(4) Altamira Holding AG (5) Mr Adriano Agosti

 

 

4. Full name of shareholder(s)

(if different from 3.):iv

 

 

 

Deutsche Bank

5. Date of the transaction and date on

which the threshold is crossed or reached: v

 

15 June 2017

 

6. Date on which issuer notified:

 

15 June 2017

7. Threshold(s) that is/are crossed or reached: vi, vii

 

4%

 

 

 

  8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of

shares

 

if possible using the ISIN CODE

Situation previous

to the triggering transaction

Resulting situation after the triggering transaction

Number

of

Shares

Number

of Voting Rights

Number

of shares

Number of voting

rights

% of  voting rights x

 

Direct

xi

Direct

xii

Indirect

 

Direct

 

Indirect

 

GB0009390070

 

 

3'627'761

 

 

3'627'761

 

 

0

 

 

0

 

 

3'597'761

 

 

0

 

 

3.98%

 

 

B: Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

Type of financial

instrument

Expiration date xiii

Exercise/

Conversion Period xiv

Number of voting

rights that may be acquired if the instrument is exercised/ converted.

% of voting

rights

 

 

N/A

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

xv, xvi

 

Resulting situation after the triggering transaction

Type of financial

instrument

Exercise

price

Expiration date xvii

Exercise/

Conversion period xviii

Number of voting rights

instrument refers to

% of voting rights xix,

xx

 

 

N/A

 

Nominal

 

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

3'597'761

 

3.98%

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

 

GoldenPeaks Active Value Limited is a parent undertaking of GoldenPeaks Limited.

 

Altamira Holding AG is a parent undertaking of GoldenPeaks Capital Management Limited, and

Mr Adriano Agosti is a parent undertaking of Altamira Holding AG.

 

 

 

 

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

 

 

13. Additional information:

 

14. Contact name:

Ivano Rizzuto ir@goldenpeakscapital.com

 

15. Contact telephone number:

 

+41 41 444 10 61

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFAMITMBABBTR
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.